Press release
Cardiovascular Prosthetic Device Market Gains Momentum in Structural Heart Therapies CAGR 8.4% (2023-2030) | Top Companies 2025 - Abbott Laboratories, Boston Scientific Corporation, Lepu Medical Technology Co. Ltd
"Global Cardiovascular Prosthetic Device Market reached US$ 15.3 billion in 2022 and is expected to reach US$ 28.9 billion by 2030 growing with a CAGR of 8.4% during the forecast period 2023-2030." As per DataM intelligence research reportAs per our analysis The Cardiovascular Prosthetic Device market is growing swiftly with increasing cases of heart disease and aging populations. Breakthroughs in transcatheter valves, stents, and leadless pacemakers are transforming patient recovery. Biocompatible materials and 3D-printed implants are enhancing durability and personalization. Hospitals are rapidly adopting these devices for minimally invasive cardiac procedures. North America leads the market, while Asia-Pacific is witnessing rapid expansion. This market is redefining cardiac care with innovation, precision, and life-saving impact.
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/cardiovascular-prosthetic-device-market?sp
Cardiovascular Prosthetic Device Market Drivers:
The cardiovascular prosthetic device market is driven by the rising prevalence of cardiovascular diseases, including heart valve disorders and vascular blockages. Increasing geriatric population and sedentary lifestyles contribute to higher incidence rates. Technological advancements in biocompatible materials and minimally invasive implantation techniques are enhancing device performance. Growing awareness about cardiovascular health and early diagnosis is supporting demand. Expansion of healthcare infrastructure and rising surgical procedures further boost market growth. Government initiatives promoting heart disease prevention also play a role.
Market growth is fueled by increasing adoption of devices such as heart valves, stents, and vascular grafts in treatment protocols. Innovations in biodegradable and drug-eluting prosthetics improve patient outcomes and reduce complications. Rising number of cardiac surgeries worldwide drives equipment demand. Emerging markets show potential due to improving healthcare access and affordability. Collaborations between medical device manufacturers and healthcare providers accelerate product development. Continuous research and clinical trials are expanding the range of cardiovascular prosthetic solutions.
Cardiovascular Prosthetic Device Market: Recent Industry Developments
✅In July 2025 Announced acquisition of Monogram Technologies for USD 177 million to advance its surgical robotics platform, including semi-autonomous knee replacement systems-reflecting broader device strategy and automation synergy. While not specific to cardiac prosthetics, it emphasizes Zimmer's instrumentation ambitions across surgical domains.
Strategic Players Driving the Cardiovascular Prosthetic Device Market Forward:
The major global players in the cardiovascular prosthetic device market include Abbott Laboratories, Boston Scientific Corporation, Lepu Medical Technology Co. Ltd, Medtronic Inc, Biotronik, Meril Life Sciences Pvt. Ltd, Pacetronix, MicroPort Scientific Corporation, Artivion, Inc, and JC Medical, Inc among others.
Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/cardiovascular-prosthetic-device-market?sp
Research Methodology:
The global Cardiovascular Prosthetic Device Market research report employs a comprehensive dual-source approach, integrating both primary and secondary data collection methods to ensure robust market analysis. Our research framework systematically evaluates multiple industry-influencing variables, including regulatory frameworks and government policies, prevailing market conditions, competitive intensity levels, historical performance data, current market positioning, technological innovations and disruptions, emerging industry developments, cross-sector business impacts, market volatility patterns, growth prospects, potential market barriers, and strategic challenges facing industry participants.
Segment Covered in the Cardiovascular Prosthetic Device Market:
♦By Product Type: Pacemakers, Implanted Heart Valves, Stents, Others
♦By End User: Hospitals, Clinics/Cardiac Centers, Ambulatory Surgical Centers, Others
Regional Analysis for Cardiovascular Prosthetic Device Market:
The Cardiovascular Prosthetic Device market is expanding globally due to the increasing prevalence of cardiovascular diseases. North America, led by the U.S., dominates with advanced healthcare systems and high adoption of valve replacements and vascular grafts. Europe, including Germany, France, and the U.K., shows strong growth supported by aging populations and technological advancements. Asia-Pacific, particularly China, India, and Japan, is rapidly growing with rising healthcare investments and cardiac care awareness. South America, especially Brazil and Argentina, is gradually adopting prosthetic devices with improving surgical capabilities. The Middle East & Africa are witnessing emerging growth, driven by rising heart disease cases and enhanced healthcare infrastructure.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=cardiovascular-prosthetic-device-market?sp
Unlock 360° Market Intelligence with DataM Subscription Services:
https://www.datamintelligence.com/reports-subscription?sp
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cardiovascular Prosthetic Device Market Gains Momentum in Structural Heart Therapies CAGR 8.4% (2023-2030) | Top Companies 2025 - Abbott Laboratories, Boston Scientific Corporation, Lepu Medical Technology Co. Ltd here
News-ID: 4108549 • Views: …
More Releases from DataM intelligence 4 Market Research LLP

Chlamydia Infection Treatment Market Grows with Enhanced STI Screening and Antib …
The Global Chlamydia Infection Treatment Market reached US$ 1.71 billion in 2023 and is expected to reach US$ 2.46 billion by 2031, growing at a CAGR of 4.7% during the forecast period 2024-2031.
Chlamydia Infection Treatment Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With a focus on emerging drug technologies, evolving treatment paradigms,…

Next Generation Packaging Market to Reach USD 45.8 Billion by 2031, Fueled by Ac …
"The Global Next Generation Packaging Market was valued at USD 27.4 billion in 2022 and is projected to reach approximately USD 45.8 billion by 2031, expanding at a compound annual growth rate (CAGR) of 7.1% between 2024 and 2031."According to a comprehensive industry study conducted by DataM Intelligence
This significant growth is driven by the rising adoption of active packaging, intelligent packaging, and modified atmosphere packaging (MAP) across key industries including…

Pulsed Lavage Devices Market Attracts Investments in Disposable System Innovatio …
"Global Pulsed Lavage Devices Market reached USD 323.8 million in 2022 and is expected to reach USD 603.9 million by 2030 growing with a CAGR of 8.3% during the forecast period 2023-2030." As per DataM intelligence research report
As per our analysis The Pulsed Lavage Devices market is expanding rapidly with rising adoption in orthopedic, trauma, and wound care surgeries. These systems offer targeted irrigation, enhancing debridement while minimizing infection risk.…

Tissue Processing Systems Market Gains Momentum with Technological Upgrades CAGR …
"Global Tissue Processing Systems Market reached USD 383.2 million in 2022 and is expected to reach USD 578.6 million by 2030 growing with a CAGR of 5.4% during the forecast period 2023-2030." As per DataM intelligence research report
As per our analysis The Tissue Processing Systems market is gaining traction as pathology labs and hospitals upgrade to faster, more reliable automation. Modern systems deliver consistent specimen preparation, reducing manual errors and…
More Releases for Cardiovascular
Impact Of Increasing Cardiovascular Disease Patients On The Cardiovascular Infor …
The Cardiovascular Information System Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Cardiovascular Information System Market Size and Its Estimated Growth Rate?
The cardiovascular information system market has seen strong growth in recent years. It will rise from $1.16 billion in 2024…
Rising Incidence Of Cardiovascular Diseases Fuels Growth Of The Cardiovascular C …
The Cardiovascular Clinical Trials Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Cardiovascular Clinical Trials Market Size During the Forecast Period?
The cardiovascular clinical trials market has grown consistently in recent years. It will grow from $5.34 billion in 2024 to $5.73…
Surge In Cardiovascular Diseases Fuels Growth Of Cardiovascular Digital Solution …
The Cardiovascular Digital Solutions Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Cardiovascular Digital Solutions Market Size During the Forecast Period?
The market size for cardiovascular digital solutions has been experiencing robust growth in the past few years. The forecast suggests it…
Rising Incidence Of Cardiovascular Diseases Fuels Growth Of The Cardiovascular C …
What combination of drivers is leading to accelerated growth in the cardiovascular clinical trials market?
The upward trend in cardiovascular diseases is predicted to propel the cardiovascular clinical trials market's expansion. Cardiovascular disease is a term that encompasses a range of conditions impacting the heart and blood vessels including coronary artery disease, heart failure, and stroke. A rise in cardiovascular diseases can be attributed to multiple factors like inactive lifestyles, poor…
Primary Catalyst Driving Cardiovascular Information System Market Evolution in 2 …
Which drivers are expected to have the greatest impact on the over the cardiovascular information system market's growth?
The cardiovascular information system market is predicted to expand due to the growing population of patients suffering from cardiovascular diseases. Cardiovascular disease, commonly abbreviated as CVD, encompasses a variety of conditions that involve the obstruction or narrowing of blood vessels, potentially leading to serious issues such as heart attacks, strokes, or angina. The…
Rising Incidence Of Cardiovascular Diseases Fuels Growth Of The Cardiovascular C …
What combination of drivers is leading to accelerated growth in the cardiovascular clinical trials market?
The upward trend in cardiovascular diseases is predicted to propel the cardiovascular clinical trials market's expansion. Cardiovascular disease is a term that encompasses a range of conditions impacting the heart and blood vessels including coronary artery disease, heart failure, and stroke. A rise in cardiovascular diseases can be attributed to multiple factors like inactive lifestyles, poor…